Index RUT
P/E 42.25
EPS (ttm) 1.72
Insider Own 2.38%
Shs Outstand 57.31M
Perf Week 0.54%
Market Cap 4.20B
Forward P/E 22.54
EPS next Y 3.23
Insider Trans -2.15%
Shs Float 56.38M
Perf Month 2.32%
Income 100.18M
PEG 3.67
EPS next Q 0.76
Inst Own 97.12%
Short Float / Ratio 1.61% / 2.95
Perf Quarter 11.35%
Sales 1.22B
P/S 3.44
EPS this Y 9.76%
Inst Trans 2.03%
Short Interest 0.91M
Perf Half Y -13.80%
Book/sh 21.30
P/B 3.41
EPS next Y 8.83%
ROA 5.82%
Target Price 86.25
Perf Year 0.99%
Cash/sh 1.05
P/C 69.14
EPS next 5Y 11.50%
ROE 8.64%
52W Range 62.58 - 85.62
Perf YTD 2.96%
Dividend -
P/FCF 58.92
EPS past 5Y 18.63%
ROI 6.38%
52W High -15.08%
Beta 0.90
Dividend % -
Quick Ratio 1.50
Sales past 5Y 9.82%
Gross Margin 42.56%
52W Low 16.19%
ATR 1.57
Employees 6846
Current Ratio 3.13
Sales Q/Q 10.04%
Oper. Margin 9.80%
RSI (14) 59.53
Volatility 1.78% 1.95%
Optionable Yes
Debt/Eq 0.29
EPS Q/Q 66.89%
Profit Margin 8.20%
Rel Volume 0.86
Prev Close 71.56
Shortable Yes
LT Debt/Eq 0.28
Earnings Oct 26 AMC
Payout 0.00%
Avg Volume 306.98K
Price 72.71
Recom 1.62
SMA20 1.87%
SMA50 5.93%
SMA200 -1.53%
Volume 262,578
Change 1.61%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-20-22 Downgrade
Canaccord Genuity
Buy → Hold
$73 → $72
Jan-05-21 Upgrade
Needham
Hold → Buy
$65
Sep-28-20 Upgrade
Wells Fargo
Underweight → Equal Weight
$42
Feb-25-20 Downgrade
Barrington Research
Outperform → Mkt Perform
Feb-03-20 Upgrade
Raymond James
Mkt Perform → Outperform
$43
Dec-12-19 Downgrade
Wells Fargo
Market Perform → Underperform
$26
Sep-24-19 Initiated
Oppenheimer
Outperform
Sep-10-19 Downgrade
Raymond James
Outperform → Mkt Perform
Jul-26-19 Downgrade
Wells Fargo
Outperform → Market Perform
Jul-26-19 Downgrade
Needham
Buy → Hold
Oct-02-18 Reiterated
Needham
Buy
$67 → $73
Aug-07-18 Downgrade
BofA/Merrill
Buy → Underperform
Jul-24-18 Reiterated
Needham
Buy
$54 → $67
Jun-01-18 Reiterated
Needham
Buy
$54
May-18-18 Reiterated
SunTrust
Buy
$55 → $62
Apr-26-18 Reiterated
Needham
Buy
$53 → $54
Apr-20-18 Initiated
Needham
Buy
$53
Mar-01-18 Upgrade
Barrington Research
Mkt Perform → Outperform
$50
Aug-28-17 Downgrade
Raymond James
Strong Buy → Outperform
Jul-20-17 Initiated
BofA/Merrill
Buy
$44
Show Previous Ratings
Nov-15-23 07:28AM
Nov-01-23 09:55AM
Oct-31-23 11:40AM
Oct-30-23 01:37AM
Oct-27-23 12:20PM
11:16AM
Loading…
11:16AM
10:51AM
(Thomson Reuters StreetEvents)
Oct-26-23 07:30PM
05:50PM
05:48PM
04:40PM
(Associated Press Finance)
04:05PM
07:52AM
Oct-25-23 10:21AM
Oct-12-23 11:55AM
11:40AM
Loading…
Oct-10-23 11:40AM
09:25AM
Oct-05-23 11:05AM
09:25AM
Sep-19-23 09:00AM
Sep-07-23 07:22AM
Sep-06-23 09:25AM
Aug-30-23 12:46PM
Aug-15-23 01:20PM
Aug-10-23 07:58AM
Aug-08-23 06:50AM
Aug-03-23 09:25AM
Jul-26-23 12:07PM
Jul-25-23 08:00PM
05:45PM
04:43PM
Loading…
04:43PM
04:05PM
Jul-21-23 06:51AM
Jul-13-23 11:56AM
Jul-11-23 11:40AM
Jul-07-23 07:20AM
Jul-06-23 01:11PM
Jul-03-23 07:51AM
Jun-26-23 10:50AM
Jun-22-23 11:40AM
Jun-21-23 08:00PM
11:35AM
Jun-19-23 10:24AM
Jun-14-23 11:51AM
11:22AM
Jun-13-23 01:59PM
11:22AM
Jun-09-23 01:39PM
Jun-08-23 04:01PM
12:44PM
Jun-07-23 04:23PM
01:53PM
12:52PM
Jun-06-23 12:37PM
10:20AM
Jun-05-23 02:12PM
11:45AM
Jun-02-23 12:44PM
Jun-01-23 11:28AM
11:17AM
10:14AM
May-31-23 12:07PM
12:04PM
May-26-23 11:31AM
10:55AM
May-25-23 02:30PM
02:29PM
May-24-23 01:42PM
10:14AM
May-23-23 11:23AM
11:04AM
11:01AM
May-22-23 11:13AM
11:10AM
10:48AM
May-19-23 11:39AM
10:48AM
08:41AM
May-18-23 01:12PM
01:09PM
10:50AM
May-17-23 02:15PM
09:40AM
May-16-23 02:35PM
02:32PM
May-15-23 01:10PM
May-11-23 01:04PM
10:08AM
May-10-23 10:53AM
May-04-23 10:53AM
May-03-23 11:35AM
May-01-23 10:34AM
Apr-28-23 01:27PM
12:00PM
09:15AM
Apr-27-23 08:21AM
(Thomson Reuters StreetEvents) +5.27%
Apr-26-23 09:00PM
08:00PM
05:45PM
04:05PM
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
LAMPROPOULOS FRED P PRESIDENT AND CEO Aug 25 Option Exercise 28.20 200,000 5,640,000 1,167,916 Aug 29 06:08 PM LAMPROPOULOS FRED P PRESIDENT AND CEO Aug 25 Option Exercise 28.20 6,000 169,200 12,888 Aug 29 06:08 PM Peterson Neil CHIEF OPERATING OFFICER Aug 22 Option Exercise 28.20 8,000 225,600 8,000 Aug 23 11:32 AM Peterson Neil CHIEF OPERATING OFFICER Aug 22 Sale 67.91 8,000 543,288 0 Aug 23 11:32 AM ANDERSON A SCOTT Director Aug 09 Option Exercise 50.50 25,000 1,262,500 71,397 Aug 11 05:30 PM ANDERSON A SCOTT Director Aug 09 Sale 69.40 22,180 1,539,292 49,217 Aug 11 05:30 PM Peterson Neil CHIEF OPERATING OFFICER Mar 16 Option Exercise 28.20 8,000 225,600 8,000 Mar 20 04:44 PM Peterson Neil CHIEF OPERATING OFFICER Mar 16 Sale 68.75 8,000 550,000 0 Mar 20 04:44 PM LAMPROPOULOS FRED P PRESIDENT AND CEO Mar 14 Sale 68.26 24,977 1,705,052 967,916 Mar 16 06:01 PM Voigt Michel James CHIEF HUMAN RESOURCES OFFICER Mar 14 Sale 68.31 2,000 136,620 515 Mar 15 01:34 PM Ward Lynne Director Mar 08 Option Exercise 34.46 2,000 68,920 17,549 Mar 10 06:32 PM Ward Lynne Director Mar 08 Sale 66.71 11,585 772,789 5,964 Mar 10 06:32 PM ANDERSON A SCOTT Director Mar 06 Option Exercise 29.20 15,000 438,000 62,135 Mar 08 12:49 PM ANDERSON A SCOTT Director Mar 06 Sale 66.74 15,000 1,001,160 47,135 Mar 08 12:49 PM Parra Raul Jr. CFO AND TREASURER Mar 03 Sale 70.00 1,023 71,610 6,688 Mar 07 03:05 PM Parra Raul Jr. CFO AND TREASURER Mar 02 Option Exercise 37.71 6,000 226,260 19,697 Mar 03 05:54 PM LAMPROPOULOS FRED P PRESIDENT AND CEO Mar 02 Sale 69.86 19,176 1,339,616 992,893 Mar 02 08:18 PM Parra Raul Jr. CFO AND TREASURER Mar 02 Sale 70.00 11,986 839,020 7,711 Mar 03 05:54 PM LAMPROPOULOS FRED P PRESIDENT AND CEO Mar 01 Sale 70.17 1,483 104,068 1,012,069 Mar 02 08:18 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite